| Ytd | -1.64% | |
| 1y | -11.16% |
| Open | 0.27 | Prev Close | 0.28 | Low | 0.27 | High | 0.28 | Mkt Cap | 27.57M |
| Vol | 59.68K | Avg Vol | 1.28M | EPS | -0.06 | P/E | N/A | Forward P/E | -3.74 |
| Beta | 1.29 | Short Ratio | 2.29 | Inst. Own | 22.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.30 | 200-d Avg | 0.32 | 1yr Est | 3.75 |
Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imagin
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p
https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amend
Approximately 80% of target participants have completed trial participation, strengthening momentum
https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3
https://www.axios.com/2026/04/22/trump-marijuana-rule-change
Behavioral neurology expertise and expanded patient access support final phase of recruitment in Alz
Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Ph
IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company") today announced that it has app
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.01) per share which beat the analyst consensu
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p
https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-progra
https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-b
IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company"), a clinical-stage pharmaceutica
IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage phar
https://www.marijuanamoment.net/new-hampshire-house-passes-bills-to-legalize-marijuana-and-let-dispe
https://www.marijuanamoment.net/congressional-leaders-drop-attempt-to-block-marijuana-rescheduling-w
https://www.marijuanamoment.net/florida-attorney-general-asks-supreme-court-to-block-marijuana-legal
https://www.marijuanamoment.net/federal-health-programs-will-cover-up-to-500-worth-of-cbd-for-certai
https://themarijuanaherald.com/2025/12/president-trump-directs-attorney-general-pam-bondi-to-finaliz
https://www.marijuanamoment.net/supreme-court-should-uphold-gun-ban-for-marijuana-users-19-state-ags
IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biot
https://www.nbcnews.com/politics/donald-trump/trump-expected-order-reclassify-cannabis-open-medical-
Effective December 12, 2025, IGC Pharma, Inc. (the "Company") amended its Amended and Restat
https://x.com/LizClaman/status/2000667074671067347?s=20
IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology
IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology
https://www.marijuanamoment.net/nebraska-supreme-court-hears-case-seeking-to-overturn-medical-mariju
This book represents an essential contribution to the global Alzheimer's community," said Ra
https://www.bloomberg.com/news/articles/2025-11-26/medicare-to-test-making-cbd-treatment-available-f
https://www.marijuanamoment.net/marijuana-banking-bill-is-on-the-back-burner-as-congressional-lawmak
https://themarijuanaherald.com/2025/11/gop-mast-reschedule-cannabis/
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which met the analyst consensus
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC)
https://patentcenter.uspto.gov/applications/18301099/ifw/docs
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clini
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clini
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm
IGC Pharma, Inc. (NYSE: IGC) today announced the addition of a new clinical trial site to its ongoin
IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's invest
IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's invest
https://www.gov.ca.gov/2025/09/22/governor-newsom-signs-legislation-cutting-taxes-on-cannabis-promot
https://www.marijuanamoment.net/marijuana-industry-group-pushes-congress-for-tax-relief-and-to-apply
https://www.marijuanamoment.net/trumps-drug-czar-pick-says-marijuana-is-a-bipartisan-issue-but-admin